Chester County News and Community Website
Neuronetics, Inc. (NASDAQ: STIM), headquartered in Malvern, PA, is a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of its NeuroSite™ Coil Placement Accessory. The state-of-the-art tool, designed to …
Neuronetics Secures FDA Clearance for NeuroSite, Streamlining Mental Health Treatments Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leading medical technology company specializing in innovative solutions for mental health, has announced that its NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy System …
Neuronetics’ NeuroStar TMS Therapy System Receives Advanced Approval in Japan, Paving the Way for Enhanced Depression Treatment Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a leading medical technology company, has announced that its management team will present at the prestigious 35th Annual Piper Sandler Healthcare Conference on …
Neuronetics to Showcase at the 35th Annual Piper Sandler Healthcare Conference Read More MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) announced this week significant updates to its proprietary NeuroStar software and TrakStar® Patient Data Management System. These enhancements aim to revolutionize patient care …
Neuronetics Unveils Major Updates to NeuroStar and TrakStar Software for Enhanced Patient Care and Data Management Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), the makers of NeuroStar Advanced Therapy, recently announced vital healthcare policy updates from Magellan, BlueCross BlueShield (BCBS) of Kansas City, and Dean Health …
Neuronetics Gets Healthcare Policy Boost: Increased Patient Access to NeuroStar Therapy Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM), a pioneer in the treatment of psychiatric disorders, announced its financial and operating results for the third quarter of 2023 this week. The …
Neuronetics Reports 8% Revenue Growth in Q3 2023, Expects Continued Momentum Read More MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced the granting of inducement awards of Restricted Stock Units representing a total of 18,000 shares of the Company’s common stock …
Neuronetics Grants Restricted Stock Units as Inducement Awards Read More